Browsing Tag
Lorbrena
2 posts
Pfizer raises revenue outlook to $64bn as non-COVID medicines grow 7%
Pfizer reported largely unchanged quarterly revenue as declining COVID-19 products and weaker Prevnar vaccine sales offset growth in oncology, cardiovascular and migraine treatments. Management raised its annual revenue and adjusted earnings forecasts, but research expenditure and continuing product competition remain important challenges.
Pfizer’s Lorbrena receives FDA approval for advanced lung cancer treatment
Pfizer Inc., a leading US pharmaceutical company, has secured approval from the US Food and Drug Administration (FDA)…